SCHEMBL6935294

SCHEMBL6935294

NC(=O)[C@H](CC(=O)O)NNC(=O)NC(=O)CC(CNc1nc2ccccc2[nH]1)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
FFAR2 O15552 1/20 0.41
PRKCZ Q05513 3/20 0.40
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ITGB1 P05556 1/20 0.36
ITGA5 P08648 1/20 0.36
CYP3A4 P08684 1/20 0.36
KCNH2 Q12809 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ITGB3 P05106 2/20 0.35
ITGAV P06756 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NOD1 Q9Y239 1/20 0.35
MEN1 O00255 1/20 0.35
GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7878249 0.83 FFAR2 (0.54) KDM4EFFAR2PRKCZRAB9ANPC1
SCHEMBL6941043 0.80 ITGB3 (0.54) ITGB1ITGB3ITGAV
SCHEMBL6941095 0.71 AKR1C3 (0.57) RAB9ANPC1HTTSMN1; SMN2ALDH1A1
SCHEMBL3538175 0.70 RAB9A (0.55) KDM4EFFAR2RAB9ANPC1HTT
SCHEMBL2302990 0.66 PRKCZ (0.76) KDM4EPRKCZRAB9ANPC1SMN1; SMN2
Hydrochloric Acid SCHEMBL658839 0.65 PRKCZ (0.74) KDM4EPRKCZRAB9ANPC1SMN1; SMN2
SCHEMBL6763140 0.65 ITGAV (0.56) KDM4EFFAR2PRKCZRAB9ANPC1
SCHEMBL8328333 0.62 ALPL (0.64) RAB9ANPC1HTTSMN1; SMN2CYP3A4
SCHEMBL3541921 0.62 RAB9A (0.62) RAB9ANPC1HTTSMN1; SMN2CYP3A4
SCHEMBL3543587 0.61 FFAR2 (0.54) KDM4EFFAR2RAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097127-B1 DIACYLHYDRAZINE DERIVATIVES AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2003-03-12 EP disclosed
US-6326403-B1 CARDIOVASCULAR DISORDERS MERCK PATENT GESELLSCHAFT MIT (DE) 2001-12-04 US disclosed